Study of Bepirovirsen in Participants Living With Human Immunodeficiency Virus and Chronic Hepatitis B Virus Infection (B-Focus)
Clinical trial NCT06497504 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06497504
- Sponsor
- GlaxoSmithKline
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-17
- Primary completion
- 2027-04-22
- Enrollment
- 153
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.